Reagents and assays to test on the Panther Fusion

The requiring activity for this action is the Diagnostics and Countermeasures Branch (DCB) within Walter Reed Army Institute of Research (WRAIR). WRAIR requests a firm-fixed-price contract with Gen Probe to acquire reagents and assays to test on the Panther Fusion open access platform for the clinical Panther system currently deployed within DCB and implement Gen Probe Coronavirus and Gen Probe SARS-CoV-2 EUA assays. Gen-Probe is the only vendor that can provide proprietary services and consumables for the Panther System. WRAIR has a public responsibility to comply with the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) guidance to prevent further spread of COVID-19. They are also required to comply with Department of Defense and U.S. Army Europe guidance to implement plans to ensure compliance with directed force health protection measures throughout the area of operations in order to prevent an outbreak of COVID-19 within U.S. personnel (service members, civilians, contractors, and dependents) or confine it to as small a population as possible.